An 'extraordinary' new class of drugs are set to undergo human trials after researchers believe they could become the first ...

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously "undruggable" cancer-driving ...

In the battle against aggressive breast cancer, a once-elusive target is now within reach—thanks to a breakthrough from a ...

Explore how artificial intelligence is changing cancer care and what it means for the future of precision oncology.

Compounds developed through collaboration with Variational AI show targeted activityVANCOUVER, British Columbia, July 23, ...

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...

MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...

Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...

Small molecule drugs are low-molecular-weight, organic compounds used to treat a wide range of conditions. Here's what you should know.

Colon cancer is often driven by cancer stem cells, which resist treatment and lead to relapse. In a recent study, researchers ...